All lobbying filings

INVARIANT LLC

INVARIANT LLC filed a Q3 report for KERECIS on October 20, 2025, reporting $70,000 in lobbying income.

Lobbying for KERECIS · Biotechnology company

All filings by INVARIANT LLC · Everything KERECIS has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$70,000

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Educate policymakers about advanced wound care technologies and patient access to skin substitutes for wound care.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem